3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with phenytoin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barberis Negra, FF; Bräuner-Osborne, H; Conti, P; De Amici, M; De Micheli, C; De Sarro, G; Frydenvang, K; Grazioso, G; Madsen, U; Nielsen, B; Roda, G; Stensbøl, TB; Toma, L | 1 |
1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and phenytoin
| Article | Year |
|---|---|
Design, synthesis, and pharmacological characterization of novel, potent NMDA receptor antagonists.
Topics: Animals; Drug Design; Male; Mice; Mice, Inbred DBA; Molecular Conformation; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2004 |